In conclusion, measuring anti-S Abs, a biomarker for predicting the neutralization capacity following vaccination, and IFN-λ3, a biomarker for determining innate immunity activation resulting from SARS-CoV-2 infection, may have clinical implications for patients with COVID-19. Here, IFNL3 is linked to COVID-19.